Weiqun Xu

Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia

The clinical utility of measurable residual disease monitoring based on next-generation sequencing in T-cell acute lymphoblastic leukemia remains incompletely defined. Here we show the prognostic value of tracking clonal T-cell receptor gene rearrangements by next-generation sequ...